|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 113 IDR | -4.24% |
|
-14.39% | -90.13% |
| May. 10 | Foreign Investment Review Board Clears Probiotec Acquisition by Pyridam Farma | MT |
| Mar. 15 | PT Pyridam Farma Tbk Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
PT Pyridam Farma Tbk reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was IDR 702,067.62 million compared to IDR 715,425.03 million a year ago. Net loss was IDR 85,220.97 million compared to net income of IDR 275,241.31 million a year ago.
Basic loss per share from continuing operations was IDR 159.27 compared to basic earnings per share from continuing operations of IDR 514.39 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -90.13% | 77.91M | |
| +42.69% | 749B | |
| +38.38% | 605B | |
| -6.87% | 351B | |
| +18.74% | 328B | |
| +6.76% | 292B | |
| +11.21% | 216B | |
| -2.58% | 214B | |
| +2.64% | 167B | |
| +6.72% | 165B |
PT PYRIDAM FARMA TBK 
